Navigation Links
Pharmac Blamed Of Depriving People of Lifesaving Drug

Two cardiologists accuse Pharmac of not properly funding the cholesterol lowering drugs to the new Zealanders. They published the report in the New Zealand medical //journal which they point out the shortsighted approach of the agency toward important drugs.

Cardiologists Dr Chris Ellis and Dr Harvey White said that the agency did not allocate funds for the statins for a period of 20 years.

Statins are drugs which help in the reduction of cholesterol levels and prevent heart problems such as heart attacks and strokes.

Pharmac's policies have limited the access of statins to the patients who were in dire need of the drug. This has increased the number of people suffering from heart problems due to inaccessibility of the drug. Hence the cardiologists accuse the agency of patient neglect and public deceit.

The statins are very efficient in lowering the cholesterol levels by about 58%. The initial clinical trails conducted during1986 is a proof for the efficiency of the drug. Despite of its efficiency the drug was not made widely available to patients in New Zealand until 1997. After which only statins which showed no mortality and low beneficial outcomes were funded by the agency.

The report by the cardiologist therefore blames Pharmac for misrepresenting scientific data, ignoring evidence based medicine and restricting access to medicine with the help of bureaucratic hurdles. This has resulted in more harm and premature death to New Zealanders.

National's Associate Health spokeswoman Jackie Blue said that the agency would have to alter its funding policy for the welfare of the people and also to attract more pharmaceutical companies.


'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Medicis Pharmaceutical company enters pediatric market
4. Pharmacies in for a dose of bitter medicine
5. Pharmacia may take 51.5 percent Abbott stake
6. Pharmaceutical companies are targeting patients
7. FDA approves Watson Pharmaceuticals Oxytrol patch
8. Pharmacist’s Role in Medication Error
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... ... HealthCareMandA.com will host an important webinar — Home Health & Hospice: Buying, ... of the webinar will also be made available following its live presentation. The webinar ... still popular targets for healthcare investors. This highly fragmented sector bounced back in 2016, ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... suburbs and South Hills of Pittsburgh now have easier access to the ... only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and ...
(Date:3/29/2017)... ... ... has helped over 1.5 million SharePoint users learn the content management system faster and ... for SharePoint was at the farm level. Enterprises using SharePoint Online in Office 365 ... recently released a modified version of the Help System, VisualSP for Site Collections, which ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati ... to directly address the resolution to globally reduce the harmful use of alcohol ... of FDA and TTB approved ingredients that when infused into alcohol, renders the ...
(Date:3/28/2017)... ... ... The Thyroid Secret is a specialized 9-part documentary series ... recently launched on March 1, and Dr. Wentz discussed varied benefits and aspects ... Wentz is a licensed pharmacist and a foremost thyroid specialist. After being diagnosed ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017   Dynatronics ... today the appointment of Cynthia L. McHenry ... will be responsible for leading Dynatronics manufacturing, distribution, ... will report to Dynatronics, CEO Kelvyn H. ... concludes an extensive search process conducted by the ...
(Date:3/29/2017)... -- FinancialBuzz.com News Commentary  ... Data published in a research report by Grand View Research, Inc., ... USD 55.8 billion by 2025. The projection takes into consideration the continuous ... a more open approach towards cannabis products around the world. In 2016, ... North Dakota , Ohio , and ...
(Date:3/28/2017)... 2017 The global emerging cancer diagnostics market ... from 2016 to 2023 and reach a figure of ... is a chronic disease and is affecting a huge ... market. This report is focused on emerging cancer diagnostics ... is propelled due to factors such as: increasing number ...
Breaking Medicine Technology: